Sol has over 20 years of experience in strategy consulting in the Healthcare and Life Sciences space. She has advised Big Pharma, Emerging Biopharma, MedTech, Diagnostics or Consumer health companies as well as Trade Associations and Providers – labs and hospitals - across a range of issues from strategy to organization and operations and from R&D to commercial.
Her areas of focus include market entry and growth strategy, go to market models, market access, affordability and innovative business models. She has experience in Europe, Asia Pacific and emerging markets.
Prior to joining EY, Sol was with the Life Sciences practice of a leading consulting firm in London and later led the consulting team of another well-known firm for Southeast Asia based in Singapore.
Sol holds an BA in Politics and Economics and an MBA from IESE Business School.
“I work closely with my clients to improve their performance and impact in moment that is historic for the health and wellness industry. Health care and life sciences players are facing significant disruption across the value chain, from R&D models, through to care delivery and financing needs. Ultimately, EY clients thriving leads to better prevention and care and broader access to innovative technologies for patients and consumers, thus enabling better outcomes and longer, better lives for all of us.
I am a passionate advocate of our diversity and inclusion agenda and a strong supporter of new female talent as they take on more prominent and leading roles.”
